Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease — Challenge

Cerebral Small Vessel Disease Clinical Trial

Official title:
A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease

Status Active, not recruiting

Clinical Trial Summary

There may be a difference in efficacy of cilostazol and aspirin on progression of white matter changes in cerebral small vessel disease.

Clinical Trial Description

The primary objective of this study is to compare the efficacy of aspirin and cilostazol on volume of white matter changes in cerebral small vessel disease.

The secondary objectives are to compare the impact of aspirin and cilostazol on DTI parameters, lacune, microbleeds, brain atrophy, cognition, depression, neurologic signs, gait, urination, and activities of daily living.

We also investigate risk factors associated with progression of cerebral small vessel disease. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01932203
Study type	Interventional
Source	Inha University Hospital
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	July 17, 2013
Completion date	August 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02169739` - Remote Preconditioning Over Time To Empower Cerebral Tissue	N/A
Recruiting	`NCT05356104` - GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)	Phase 2
Recruiting	`NCT05374005` - The Impact of Excessive Dietary Sodium on Brain Health
Completed	`NCT01658306` - Clinical Trial on Remote Ischemic Preconditioning and Cerebral Small Vessel Disease	Phase 3
Recruiting	`NCT05715710` - Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease
Completed	`NCT02033291` - Blood-brain Barrier Quantification in Cerebral Small Vessel Disease	N/A